Tencent, Sequoia Capital China-backed Weshine has secured 300 million yuan ($47.5 million) in two funding rounds. Separately, CICC Capital has led a Series B round in synthetic biology firm Shenzhen Siyomicro Biotech.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in